Current Neuropharmacology


Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 2, June

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

Volume:5   Issue: 2
Pp: 73-80
John C. Ashton and Michelle Glass
DOI: 10.2174/157015907780866884
Published on: 01 March, 2012

Parkinsons Disease: Genetics and Beyond

Volume:5   Issue: 2
Pp: 99-113
N. N. Inamdar, D. K. Arulmozhi, A. Tandon and S. L. Bodhankar
DOI: 10.2174/157015907780866893
Published on: 01 March, 2012

Cell and Gene Therapies for Refractory Epilepsy

Volume:5   Issue: 2
Pp: 115-125
Detlev Boison
DOI: 10.2174/157015907780866938
Published on: 01 March, 2012

Current Experimental Therapy for Alzheimers Disease

Volume:5   Issue: 2
Pp: 127-134
Sheng Chen, Xiao-Jie Zhang, Liang Li and Wei-Dong Le
DOI: 10.2174/157015907780866901
Published on: 01 March, 2012

The Neurobiological Bases for Development of Pharmacological Treatments of Aggressive Disorders

Volume:5   Issue: 2
Pp: 135-147
Allan Siegel, Suresh Bhatt, Rekha Bhatt and Steven S. Zalcman
DOI: 10.2174/157015907780866929
Published on: 01 March, 2012